Therefore, a careful approach is needed to evaluate the possibility of CSNK2A1 as a potential therapeutic target of osteosarcoma based on the effect of CSNK2A1 on the proliferation of osteosarcoma cells. Here, CSNK2A1 is linked to osteosarcoma.